http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59206349-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
filingDate 1983-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af1b1990a8171711caa8bf793791e247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f80e2fd6e5c573a287a09d521d0149c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43dc26a76e15104d8e248ea3e95c5984
publicationDate 1984-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S59206349-A
titleOfInvention Prostaglandin e1 derivative
abstract NEW MATERIAL:The compound of formula I [R 1 is alkyl; R 2 is H or lower alkyl; X is -C(CO)-O- or -O-C(O)-]. n EXAMPLE: Butoxycarbonylmethyl prostaglandin E 1 ester. n USE: Hypotensor and antithrombotic agent. It can be extremely easily converted to a fat emulsion, and has high ED 50 value. n PREPARATION: The compound of formula I can be prepared by reacting prostaglandin E 1 with the ester compound of formula II (X is halogen, OH or diazo) preferably in the presence of a phase-transfer catalyst [e.g. (CH 3 ) 4 NBr, (CH 3 H 7 ) 4 Nbr, etc.]. The compound has hypotensive and blood platelet coagulation suppressng effect, etc. The conversion of the compound to a fat emulsion is preferably carried out by conventional means using a vegetable oil such as soybean oil, cottonseed oil, etc. Dose: usually 1W100μg for an adult by intravenous injection when used as an antithrombotic agent in the form of a fat emulsion. n COPYRIGHT: (C)1984,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63246330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5445812-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9012576-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777601-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0758645-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-708905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1058706-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5690957-A
priorityDate 1983-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458418731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590105

Total number of triples: 30.